Flagship Ventures Fund IV General Partner LLC
CIK 1508051 · last filed 2022-10-17
Flagship Ventures Fund IV General Partner LLC is a corporate insider who has filed 6 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider bought $85.1M of AXLA on Oct 17, 2022. Across all open-market trades the lifetime net is +$648.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.38M
4
6
$648.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Axcella Health Inc. (AXLA) Delisted | 10%+ Owner | 14,101,638 | $0.40 | $5.65M | $193.45M | 2 | 2022-10-17 |
| EVLO | 10%+ Owner | 5,495,324 | $0.00 | $550 | $465.00M | 2 | 2022-06-01 |
| Carisma Therapeutics Inc. (EBIO) Delisted | 10%+ Owner | 1,833,802 | — | — | -$9.98M | 1 | 2016-09-21 |
| EDIT | 10%+ Owner | 2,953,687 | $2.50 | $7.38M | $0 | 1 | 2016-02-09 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-17 | Axcella Health Inc. (AXLA) Delisted | Buy (P) | +51,918,800 | $85.15M | EDGAR |
| 2022-06-01 | EVLO | Buy (P) | +246,575,331 | $360.00M | EDGAR |
| 2020-07-01 | EVLO | Buy (P) | +27,999,996 | $105.00M | EDGAR |
| 2020-05-20 | Axcella Health Inc. (AXLA) Delisted | Buy (P) | +22,800,000 | $108.30M | EDGAR |
| 2016-09-21 | Carisma Therapeutics Inc. (EBIO) Delisted | Sell (S) | −2,704,380 | -$9.98M | EDGAR |
| 2016-02-09 | EDIT | Conv (C) | +24,776,580 | $0 | EDGAR |